Free Trial

Totally (TLY) Competitors

Totally logo
GBX 3.68 -0.87 (-19.12%)
As of 02/21/2025 12:16 PM Eastern

TLY vs. KNB, SPI, MGP, SBI, STX, NCYT, COS, C4XD, DDDD, and POLB

Should you be buying Totally stock or one of its competitors? The main competitors of Totally include Kanabo Group (KNB), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Shield Therapeutics (STX), Novacyt (NCYT), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), and Poolbeg Pharma (POLB). These companies are all part of the "medical" sector.

Totally vs.

Kanabo Group (LON:KNB) and Totally (LON:TLY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, community ranking, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Totally has higher revenue and earnings than Kanabo Group. Totally is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M4.11-£8.18M-£1.29-0.57
Totally£133.05M0.05-£3.79M-£1.93-1.91

Kanabo Group has a beta of 3.04, meaning that its share price is 204% more volatile than the S&P 500. Comparatively, Totally has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.

Totally has a consensus target price of GBX 20, suggesting a potential upside of 443.48%. Given Totally's stronger consensus rating and higher probable upside, analysts clearly believe Totally is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Totally
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

3.8% of Kanabo Group shares are owned by institutional investors. Comparatively, 51.3% of Totally shares are owned by institutional investors. 37.0% of Kanabo Group shares are owned by company insiders. Comparatively, 13.3% of Totally shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Totally received 131 more outperform votes than Kanabo Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Kanabo GroupN/AN/A
TotallyOutperform Votes
131
72.78%
Underperform Votes
49
27.22%

Totally has a net margin of -2.85% compared to Kanabo Group's net margin of -717.63%. Totally's return on equity of -11.01% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-717.63% -121.77% -20.89%
Totally -2.85%-11.01%-2.42%

In the previous week, Kanabo Group and Kanabo Group both had 1 articles in the media. Totally's average media sentiment score of 0.15 beat Kanabo Group's score of 0.00 indicating that Totally is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kanabo Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Totally
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Totally beats Kanabo Group on 11 of the 16 factors compared between the two stocks.

Get Totally News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLY vs. The Competition

MetricTotallyMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£7.23M£1.49B£5.82B£2.63B
Dividend Yield13.16%3.83%4.77%4.98%
P/E Ratio-1.917.1818.92163.09
Price / Sales0.0532.73453.29312,084.09
Price / Cash9.0812.5143.8428.02
Price / Book0.212.007.645.14
Net Income-£3.79M£58.65M£3.18B£5.73B
7 Day Performance-24.90%-1.30%-1.95%-1.00%
1 Month Performance-54.74%-0.19%-0.23%-0.81%
1 Year Performance-38.67%6.64%16.69%39.25%

Totally Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLY
Totally
2.6988 of 5 stars
GBX 3.68
-19.1%
GBX 20
+443.5%
-39.9%£7.23M£133.05M-1.911,668News Coverage
High Trading Volume
KNB
Kanabo Group
N/AGBX 0.82
-4.0%
N/A-61.1%£5.16M£1.14M-0.6320News Coverage
SPI
Spire Healthcare Group
1.7254 of 5 stars
GBX 229
-0.2%
GBX 322
+40.6%
-4.4%£919.59M£1.44B32.59420
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap Up
High Trading Volume
STX
Shield Therapeutics
N/AGBX 3.61
-6.2%
N/A+30.9%£35.63M£20.92M-0.9340,000Positive News
NCYT
Novacyt
N/AGBX 49.63
-0.9%
N/A+0.6%£34.29M£18.12M-0.91120News Coverage
Gap Down
COS
Collagen Solutions plc (COS.L)
N/AN/AN/AN/A£30.99M£4.01M-8.283,350
C4XD
C4X Discovery
N/AN/AN/AN/A£30.27M£24.68M300.0049High Trading Volume
DDDD
4D pharma
N/AN/AN/AN/A£30.05M£718,000.00-1.08106
POLB
Poolbeg Pharma
N/AGBX 4.97
+1.4%
N/A-64.1%£25.54MN/A-0.0112News Coverage
Gap Down

Related Companies and Tools


This page (LON:TLY) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners